Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001667 · ClinicalTrials.gov registry record

Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases

A clinical trial of Movement Disorders and Nervous System Diseases, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
300
Enrollment target
1
Study location

NCT00001667: Completed study of Movement Disorders and Nervous System Diseases, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00001667 is a study of Movement Disorders and Nervous System Diseases that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 300 participants, below the 1,056-participant average among 26 other Movement Disorders trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001667, a study of Movement Disorders and Nervous System Diseases, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

The purpose of this protocol is to identify families with inherited neurologic conditions, especially movement disorders, to evaluate affected and unaffected individuals clinically, and to obtain blood samples for genetic analysis.

Study Locations (1)

Maryland

  • National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 1997-03
Est. Completion 2000-04

What the finished NCT00001667 record still lists

NCT00001667 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,056-participant average among 26 other Movement Disorders trials with a reported enrollment target (72% lower).

The record links to 5 conditions, with Movement Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT00001667 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00001667 about?

NCT00001667 is a clinical study titled "Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases". The purpose of this protocol is to identify families with inherited neurologic conditions, especially movement disorders, to evaluate affected and unaffected individuals clinically, and to obtain blood samples for genetic analysis.

What is the current status of trial NCT00001667?

This trial is currently completed. The enrollment target is 300 participants. The study started on 1997-03. Estimated completion is 2000-04.

What conditions does trial NCT00001667 study?

This clinical trial studies the following conditions: Movement Disorders, Nervous System Diseases, Tremor, Tic Disorders, Myoclonus.

Who is sponsoring clinical trial NCT00001667?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001667 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Movement Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00001667's enrollment target sits among peer trials

300 8th of 26 higher than 19 of 26 other Movement Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Movement Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00001667, the US trial registry maintained by the National Library of Medicine. NCT00001667 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.